Use of neuromuscular blocking agents in mechanically ventilated patients with COVID-19: A propensity score analysis

G. Li Bassi (Chermside, Australia), K. Gibbons (Brisbane, Australia), J. Suen (Chermside, Australia), H. Dalton (Falls Church, United States of America), N. White (Brisbane, Australia), A. Corley (Chermside, Australia), S. Hinton (Chermside, Australia), S. Forsyth (Brisbane, Australia), J. Laffey (Galway, Australia), D. Brodie (NY, United States of America), A. Burrell (Melbourne, Australia), E. Fan (Toronto, Canada), R. Bartlett (Ann Arbor, United States of America), A. Torres (Barcelona, Spain), D. Chiumello (Milan, Italy), A. Elhazmi (Riyadh, Saudi Arabia), C. Hodgson (Melbourne, Australia), S. Ichiba (Tokyo, Japan), C. Luna (Buenos Aires, Argentina), S. Murthy (Vancouver, Canada), A. Nichol (Dublin, Ireland), P. Ng (Hong Kong, China), M. Panigada (Milan, Italy), J. Fraser (Chermside, Australia)

Source: Virtual Congress 2021 – COVID-19 acute respiratory distress syndrome
Session: COVID-19 acute respiratory distress syndrome
Session type: Oral Presentation
Number: 1259

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Li Bassi (Chermside, Australia), K. Gibbons (Brisbane, Australia), J. Suen (Chermside, Australia), H. Dalton (Falls Church, United States of America), N. White (Brisbane, Australia), A. Corley (Chermside, Australia), S. Hinton (Chermside, Australia), S. Forsyth (Brisbane, Australia), J. Laffey (Galway, Australia), D. Brodie (NY, United States of America), A. Burrell (Melbourne, Australia), E. Fan (Toronto, Canada), R. Bartlett (Ann Arbor, United States of America), A. Torres (Barcelona, Spain), D. Chiumello (Milan, Italy), A. Elhazmi (Riyadh, Saudi Arabia), C. Hodgson (Melbourne, Australia), S. Ichiba (Tokyo, Japan), C. Luna (Buenos Aires, Argentina), S. Murthy (Vancouver, Canada), A. Nichol (Dublin, Ireland), P. Ng (Hong Kong, China), M. Panigada (Milan, Italy), J. Fraser (Chermside, Australia). Use of neuromuscular blocking agents in mechanically ventilated patients with COVID-19: A propensity score analysis. 1259

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Daily weanscreen in mechanically ventilated patients; effects on sedation, analgesics and duration
Source: Annual Congress 2011 - The eclectic world of respiratory nursing
Year: 2011


Prognostic value of residual hypoventilation in mechanically ventilated neuromuscular patients: A 5 years follow-up study
Source: International Congress 2015 – Innovations in noninvasive ventilation: is it always gold that glitters?
Year: 2015

An appraisal of respiratory system compliance in mechanically ventilated COVID-19 patients
Source: Virtual Congress 2021 – Respiratory failure in COVID19 and beyond
Year: 2021


Sedation in COPD patients mechanically ventilated due to acute respiratory failure: the prognostic effects of its duration more than 24 hours
Source: Eur Respir J 2006; 28: Suppl. 50, 395s
Year: 2006

Effectiveness of four early-rehabilitation techniques in sedated and ventilated patients in ICU
Source: International Congress 2018 – Muscle adaptations in response to physiotherapeutic interventions in acute and chronic settings
Year: 2018

Impact of sleep alterations on weaning duration in mechanically ventilated patients: a prospective study
Source: Eur Respir J, 51 (4) 1702465; 10.1183/13993003.02465-2017
Year: 2018



Risk factors and prognostic impact of decreased breathing variability in mechanically ventilated patients. A prospective study
Source: International Congress 2015 – Acute critical care: mechanical ventilation: how to limit the damage
Year: 2015


Characteristics and outcomes of mechanically ventilated patients in an adult mixed ICU
Source: Annual Congress 2009 - Intensive care unit management and outcome
Year: 2009

Determination of the best threshold to initiate inspiratory muscle training in mechanically ventilated patients
Source: Annual Congress 2008 - Mucociliary clearance, novel techniques and assessments, in adult, paediatric and mechanically ventilated patients
Year: 2008


Feasibility and safety of a new method of broncoscopy in mechanically ventilated patients
Source: Eur Respir J 2005; 26: Suppl. 49, 530s
Year: 2005

Influence of respiratory infections on survival of mechanically ventilated patients
Source: Eur Respir J 2004; 24: Suppl. 48, 547s
Year: 2004

Nonlinear approach of respiratory mechanics in mechanically ventilated COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 481s
Year: 2001

Impact of sleep alterations on weaning duration of mechanically ventilated patients: how much is bad?
Source: Eur Respir J, 52 (1) 1800979; 10.1183/13993003.00979-2018
Year: 2018



Impact of sleep alterations on weaning duration of mechanically ventilated patients: how much is bad?
Source: Eur Respir J, 52 (1) 1800925; 10.1183/13993003.00925-2018
Year: 2018



In vitro evaluation of a novel ventilation chamber (VC) for delivery of aerosolized medication to the mechanically ventilated premature infant
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009


Risk factors and prognostic impact of patient-ventilator asynchrony in mechanically ventilated patients. A prospective study
Source: International Congress 2015 – Acute critical care: mechanical ventilation: how to limit the damage
Year: 2015


A new method to measure cough pressure in intubated patients. Validity and usefulness as a predictor of extubation failure in ICU patients having succeded a spontaneous breathing trial
Source: Annual Congress 2013 –Mechanical ventilation and weaning
Year: 2013


Treatment modalities in home mechanically ventilated patients. Report from a national database
Source: Annual Congress 2005 - Chronic care in respiratory failure
Year: 2005